Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion

Molecular Cancer Therapeutics

Volumn 2, Issue 11, 2003, Pages 1085-1092

  Wang, Xueyan ^a   Le, Phuong ^a   Liang, Congxin ^a   Chan, Julie ^a   Kiewlich, David ^a   Miller, Todd ^a   Harris, Dave ^a   Sun, Li ^a   Rice, Audie ^a   Vasile, Stefan ^a   Blake, Robert A ^a   Howlett, Anthony R ^a   Patel, Neela ^a   McMahon, Gerald ^a   Lipson, Kenneth E ^a  

^a SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; INDOLE DERIVATIVE; PHOSPHOTYROSINE; PYRROLE DERIVATIVE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ARTICLE; BINDING SITE; CANCER INVASION; CELL DIVISION; CELL MOTION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHOSPHORYLATION; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BINDING SITES; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME INHIBITORS; HEPATOCYTE GROWTH FACTOR; HUMANS; INDOLES; MODELS, MOLECULAR; NEOPLASM INVASIVENESS; NEOPLASMS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-MET; PYRROLES; SIGNAL TRANSDUCTION;

EID: 17144462419     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Haddad, R., Lipson, K. E., and Webb, C. P. Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors. Anticancer Res., 21 (6B): 4243-4252, 2001. (Pubitemid 34240955)
2. Maulik, G., Shrikhande, A., Kijima, T., Ma, P. C., Morrison, P. T., and Salgi, R. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev., 13: 41-59, 2002. (Pubitemid 34436961)
3. Longati, P., Comoglio, P. M., and Bardelli, A. Receptor tyrosine kinases as therapeutic targets: the model of the Met oncogene. Curr. Drug Targets, 2: 41-55, 2001. (Pubitemid 32409744)
4. Jeffers, M., Rong, S., and Vande Woude, G. F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol., 16: 1115-1125, 1996. (Pubitemid 26061683)
5. Matsumoto, K., Date, K, Shimura, H., and Nakamura, T. Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn. J. Cancer Res., 87: 702-710, 1996. (Pubitemid 26261691)
6. Yamashita, J., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T., and Shin, S. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res., 54: 1630-1633, 1994. (Pubitemid 24116158)
7. Takada, N., Yano, Y., Matsuda, T., Otani, S., Osugi, H., Higashino, M. Kinoshita, H., and Fukushima, S. Expression of immunoreactive human hepatocyte growth factor in human esophageal squamous cell carcinomas. Cancer Lett., 97: 145-148, 1995.
8. Nagy, J., Curry, G. W., Hillan, K. J., McKay, I. C., Mallon, E., Purushotham, A. D., and George, W. D. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surg. Oncol., 5: 15-21, 1996. (Pubitemid 26235587)
9. Maemura, M., Iino, Y., Yokoe, T., Horiguchi, J., Takei, H., Koibuchi, Y., Horii, Y., Takeyoshi, I., Ohwada, S., and Morishita, Y. Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer. Cancer Lett., 126: 215-220, 1998. (Pubitemid 28181607)
10. Siegfried, J. M., Weissfeld, L. A., Luketich, J. D., Weyant, R. J., Gubish, C. T., and Landreneau, R. J. The clinical significance of hepatocyte growth factor for non-small cell lung cancer. Ann. Thorac. Surg., 66: 1915-1918, 1998. (Pubitemid 29087181)
11. Seidel, C., Børset, M., Turesson, I., Abildgaard, N., Sundan, A., and Waage, A. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. Blood, 91: 806-812, 1998. (Pubitemid 28078282)
12. Ueki, T., Fujimoto, J., Suzuki, T., Yamamoto, H., and Okamoto, E. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology, 25: 619-623, 1997. (Pubitemid 27106443)
13. Taniguchi, K., Yonemura, Y., Nojima, N., Hirono, Y., Fushida, S., Fujimura, T, Miwa, K., Endo, Y., Yamamoto, H., and Watanabe, H. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor and the urokinase-type plasminogen activator receptor. Cancer, 82: 2112-2122, 1998. (Pubitemid 28240817)
14. Wagatsuma, S., Konno, R., Sato, S., and Yajima, A. Tumor angiogenesis, hepatocyte growth factor, and c-met expression in endometrial carcinoma. Cancer, 82: 520-530, 1998. (Pubitemid 28112991)
15. Guerin, C., Luddy, C., Abounader, R., Lal, B., and Laterra, J. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor. Biochem. Biophys. Res. Commun., 273: 287-293, 2000. (Pubitemid 30426900)
16. Date, K., Matsumoto, K., Kuba, K., Shimura, H., Tanaka, M., and Nakamura, T. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene, 17: 3045-3054, 1998. (Pubitemid 29012208)
17. Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., and Nakamura, T. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res., 60: 6737-6743, 2000.
18. Tomioka, D., Maehara, N., Kuba, K., Mizumoto, K., Tanaka, M., Matsumoto, K., and Nakamura, T. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic model. Cancer Res., 61: 7518-7524, 2001. (Pubitemid 32995042)
19. Maemondo, M., Narumi, K., Saijo, Y., Usui, K., Tahara, M., Tazawa, R., Hagiwara, K., Matsumoto, K., Nakamura, T., and Nukiwa, T. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy. Mol. Ther., 5: 177-185, 2002. (Pubitemid 34144834)
20. Cao, B., Su, Y., Oskarsson, M., Zhao, P., Kort, E. J., Fisher, R. J., Wang, L-M., and Vande Woude, G. F. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc. Natl. Acad. Sci. USA, 98: 7443-7448, 2001. (Pubitemid 32567968)
21. Abounader, R., Ranganathan, S., Lal, B., Fielding, K., Book, A., Dietz, H. Burger, P., and Laterra, J. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J. Natl. Cancer Inst., 91: 1548-1556, 1999. (Pubitemid 29457959)
22. Abounader, R., Lal, R., Luddy, C., Koe, G., Davidson, B., Rosen, E. M., and Laterra, J. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. FASEB J., 16: 108-110, 2002.
23. Webb, C. P., Hose, C. D., Koochekpour, S., Jeffers, M., Oskarsson, M., Sausville, E., Monks, A., and Vande Woude, G. F. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network. Cancer Res., 60: 342-349, 2000. (Pubitemid 30070761)
24. Morotti, A., Mila, S., Accornero, P., Tagliabue, E., and Ponzetto, C. K252a inhibits the oncogenic properties of met, the HGF receptor. Oncogene, 21: 4885-4893, 2002.
25. Krystal, G. W., Honsawek, S., Kiewlich, D., Liang, C., Vasile, S., Sun, L., McMahon, G., and Lipson, K. E. Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells. Cancer Res., 61: 3660-3668, 2001. (Pubitemid 32694977)
26. Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K., Hubbard, S. R., and Schlessinger, J. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science, 276: 955-960, 1997. (Pubitemid 27209095)
27. Furge, K. A., Zhang, Y-W., and Vande Woude, G. F. Met receptor tyrosine kinase: enhanced signaling through adaptor proteins. Oncogene, 19: 5582-5589, 2000.
28. Stuart, K. A., Riordan, S. M., Lidder, S., Crostella, L., Williams, R., and Skouteris, G. G. Hepatocyte growth factor/scatter factor-induced intracellular signaling. Int. J. Exp. Pathol., 81: 17-30, 2000. (Pubitemid 30171498)
29. Weidner, K. M., Cesare, S. D., Sachs, M., Brinkmann, V., Behrens, J., and Birchmeier, W. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature, 384: 173-176, 1996. (Pubitemid 26386473)
30. Nguyen, L., Holgado-Madruga, M., Maroun, C., Fixman, E. D., Kamikura, D., Fournier, T., Charest, A., Tremblay, M. L., Wong, A. J., and Park, M. Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires functional Grb2 binding site involving tyrosine 1356. J. Biol. Chem., 272: 20811-20819, 1997. (Pubitemid 27355650)
31. Bardelli, A., Longati, P., Gramaglia, D., Stella, M. C., and Comoglio, P. M. Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential. Oncogene, 18: 3103-3111, 1997. (Pubitemid 28043489)
32. Stoker, M., Gherardi, E., Perryman, M., and Gray, J. Scatter factor is a fibroblast-derived modulator of epithelial cell motility. Nature, 327: 239-242, 1987. (Pubitemid 17071053)
33. Zhang, Y. W. and Vande Woude, G. F. HGF/SF-met signaling in the control of branching morphogenesis and invasion. J. Cell. Biochem., 88: 408-417, 2003. (Pubitemid 36119916)
34. Lipson, K. E., Pang, L., Huber, J., Chen, H., Tsai, J-M., Hirt, P., Gazit, A., Levitzki, A., and McMahon, G. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phopshorylation. J. Pharmacol. Exp. Ther., 285 (2): 844-852, 1998. (Pubitemid 28237470)